Emergent BioSolutions Inc. (EBS)

NYSE: EBS · Real-Time Price · USD

11.90

-0.15 (-1.24%)

At close: Dec 5, 2025, 4:00 PM EST

11.92

+0.02 (0.17%)

After-hours: Dec 5, 2025, 7:17 PM EST

Emergent BioSolutions Market Cap

Emergent BioSolutions has a market cap or net worth of $624.99 million as of December 5, 2025. Its market cap has increased by 34.12% in one year.

Market Cap

624.99M

Enterprise Value

1.05B

1-Year Change

34.12%

Ranking

#2895

Market Cap Chart

Since November 15, 2006, Emergent BioSolutions's market cap has increased from $320.80M to $624.99M, an increase of 94.82%. That is a compound annual growth rate of 3.56%.

Market Cap History

Date	Market Cap	% Change
Dec 4, 2025	632.90M	22.18%
Dec 31, 2024	518.00M	316.06%
Dec 29, 2023	124.50M	-78.87%
Dec 30, 2022	589.20M	-74.81%
Dec 31, 2021	2.34B	-50.75%
Dec 31, 2020	4.75B	70.50%
Dec 31, 2019	2.79B	-7.78%
Dec 31, 2018	3.02B	57.00%
Dec 29, 2017	1.92B	44.63%
Dec 30, 2016	1.33B	-14.64%
Dec 31, 2015	1.56B	52.38%
Dec 31, 2014	1.02B	22.29%
Dec 31, 2013	836.10M	45.38%
Dec 31, 2012	575.10M	-5.00%
Dec 30, 2011	605.40M	-25.67%
Dec 31, 2010	814.50M	94.58%
Dec 31, 2009	418.60M	-46.42%
Dec 31, 2008	781.20M	419.07%
Dec 31, 2007	150.50M	-50.82%
Dec 29, 2006	306.00M	-4.61%

View and export this data all the way back to 2006. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	925.43B
Johnson & Johnson	494.70B
AbbVie	406.92B
UnitedHealth Group	307.72B
AstraZeneca	283.29B
Novartis AG	257.47B
Merck & Co.	253.84B
Thermo Fisher Scientific	218.08B

Market Cap Rankings